Antiplatelets meds

Question 1

What is the target of the monoclonal antibody Abciximab?

Answer 1

GpIIb/IIIa in patients that need anti-platelet action

Question 2

What is the clinical use of the monoclonal antibody Abciximab?

Answer 2

Prevention of ischemic complications in patients undergoing percutaneous coronary intervention

Question 3

Clopidogrel, prasugrel and ticlopidine are anti-platelet drugs that irreversibly inhibit ______ on platelets, thereby preventing clumping.

Answer 3

ADP receptors

Question 4

_________ is a monoclonal antibody antiplatelet drug that interferes with GpIIb/IIIa binding to fibrinogen and other ligands.

Answer 4

Abciximab

Question 5

What type of antiplatelet/anticoagulant is Ticlopidine?

Answer 5

ADP receptor inhibitor

Question 6

What type of antiplatelet/anticoagulant is Ticagrelor?

Answer 6

ADP (P2Y12) receptor inhibitor

Question 7

What stage of platelet plug formation is inhibited by ADP Receptor Inhibitors (Clopidogrel ; Ticlopidine)?

Answer 7

Platelet aggregation

Question 8

(Med class) _________ are preferred to be used in acute coronary syndrome and coronary stenting.

Answer 8

Adenosine diphosphate receptor inhibitors

Question 9

What type of anticoagulant is Abciximab?

Answer 9

Antiplatelet; GpIIb/IIIa inhibitor

Question 10

Ticagrelor is a reversible or irreversible platelet adenosine diphosphate receptor inhibitor?

Answer 10

reversible